BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamen BA, Caston J. Properties of a Folate Binding Protein (FBP) isolated from porcine kidney. Biochemical Pharmacology 1986;35:2323-9. [DOI: 10.1016/0006-2952(86)90458-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Jansen G, Westerhof GR, Kathmann I, Rijksen G, Schornagel JH. Growth-inhibitory effects of 5,10-dideazatetrahydrofolic acid on variant murine L1210 and human CCRF-CEM leukemia cells with different membrane-transport characteristics for (anti)folate compounds. Cancer Chemother Pharmacol 1991;28:115-7. [DOI: 10.1007/bf00689699] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Zhang L, Hou S, Mao S, Wei D, Song X, Lu Y. Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells. Int J Pharm 2004;287:155-62. [PMID: 15541922 DOI: 10.1016/j.ijpharm.2004.08.015] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 5.5] [Reference Citation Analysis]
3 Hansen SI, Holm J, Høier-madsen M. A high-affinity folate binding protein in human urine. Radioligand binding characteristics, immunological properties and molecular size. Bioscience Reports 1989;9:93-7. [DOI: 10.1007/bf01117515] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Alam N, Dubey RD, Kumar A, Koul M, Sharma N, Sharma PR, Chandan BK, Singh SK, Singh G, Gupta PN. Reduced toxicological manifestations of cisplatin following encapsulation in folate grafted albumin nanoparticles. Life Sciences 2015;142:76-85. [DOI: 10.1016/j.lfs.2015.10.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
5 Johnson SP, Kamen BA, Bigner DD, Friedman HS. O (4)-benzylfolic acid inactivates O (6)-alkylguanine-DNA alkyltransferase in brain tumor cell lines. Cancer Chemother Pharmacol 2007;60:883-9. [PMID: 17333191 DOI: 10.1007/s00280-007-0435-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
6 Zhao X, Li H, Lee RJ. Targeted drug delivery via folate receptors. Expert Opin Drug Deliv 2008;5:309-19. [PMID: 18318652 DOI: 10.1517/17425247.5.3.309] [Cited by in Crossref: 225] [Cited by in F6Publishing: 200] [Article Influence: 16.1] [Reference Citation Analysis]
7 Salzer WL, Winick NJ, Wacker P, Lu X, Devidas M, Shuster JJ, Mahoney DH, Lauer SJ, Camitta BM. Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology Group. J Pediatr Hematol Oncol 2012;34:e1-7. [PMID: 21364468 DOI: 10.1097/MPH.0b013e31820ee239] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 Balashova OA, Visina O, Borodinsky LN. Folate action in nervous system development and disease. Dev Neurobiol 2018;78:391-402. [PMID: 29380544 DOI: 10.1002/dneu.22579] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
9 Tarahovsky YS. "Smart" liposomal nanocontainers in biology and medicine. Biochemistry (Mosc) 2010;75:811-24. [PMID: 20673204 DOI: 10.1134/s0006297910070023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
10 Zhang Y, Merali S, Meshnick SR. p-Aminobenzoic acid transport by normal and Plasmodium falciparum-infected erythrocytes. Molecular and Biochemical Parasitology 1992;52:185-94. [DOI: 10.1016/0166-6851(92)90051-k] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
11 Henne WA, Kularatne SA, Ayala-lópez W, Doorneweerd DD, Stinnette TW, Lu Y, Low PS. Synthesis and activity of folate conjugated didemnin B for potential treatment of inflammatory diseases. Bioorganic & Medicinal Chemistry Letters 2012;22:709-12. [DOI: 10.1016/j.bmcl.2011.10.042] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
12 Sierra EE, Brigle KE, Spinella MJ, Goldman I. pH Dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Biochemical Pharmacology 1997;53:223-31. [DOI: 10.1016/s0006-2952(96)00730-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
13 Kiekens F, Van Daele J, Blancquaert D, Van Der Straeten D, Lambert WE, Stove CP. A validated ultra-high-performance liquid chromatography–tandem mass spectrometry method for the selective analysis of free and total folate in plasma and red blood cells. Journal of Chromatography A 2015;1398:20-8. [DOI: 10.1016/j.chroma.2015.04.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
14 Spinella MJ, Brigle KE, Sierra EE, Goldman ID. Distinguishing between Folate Receptor-α-mediated Transport and Reduced Folate Carrier-mediated Transport in L1210 Leukemia Cells. Journal of Biological Chemistry 1995;270:7842-9. [DOI: 10.1074/jbc.270.14.7842] [Cited by in Crossref: 90] [Cited by in F6Publishing: 87] [Article Influence: 3.3] [Reference Citation Analysis]
15 Santiago T, DeVaux RS, Kurzatkowska K, Espinal R, Herschkowitz JI, Hepel M. Surface-enhanced Raman scattering investigation of targeted delivery and controlled release of gemcitabine. Int J Nanomedicine 2017;12:7763-76. [PMID: 29123391 DOI: 10.2147/IJN.S149306] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 4.6] [Reference Citation Analysis]
16 Van Hoozen CM, Ling EH, Halsted CH. Folate binding protein: molecular characterization and transcript distribution in pig liver, kidney and jejunum. Biochem J 1996;319 ( Pt 3):725-9. [PMID: 8920973 DOI: 10.1042/bj3190725] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
17 Holm J, Hansen SI, Høier-madsen M, Bostad L. A high-affinity folate binding protein in proximal tubule cells of human kidney. Kidney International 1992;41:50-5. [DOI: 10.1038/ki.1992.7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 1.2] [Reference Citation Analysis]
18 Henne WA, Kularatne SA, Hakenjos J, Carron JD, Henne KL. Synthesis and activity of a folate targeted monodisperse PEG camptothecin conjugate. Bioorganic & Medicinal Chemistry Letters 2013;23:5810-3. [DOI: 10.1016/j.bmcl.2013.08.113] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
19 Kamen BA, Wang MT, Streckfuss AJ, Peryea X, Anderson RG. Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. Journal of Biological Chemistry 1988;263:13602-9. [DOI: 10.1016/s0021-9258(18)68284-5] [Cited by in Crossref: 131] [Article Influence: 3.9] [Reference Citation Analysis]
20 Dixon K, Mulligan T, Chung K, Elwood P, Cowan K. Effects of folate receptor expression following stable transfection into wild type and methotrexate transport-deficient ZR-75-1 human breast cancer cells. Journal of Biological Chemistry 1992;267:24140-7. [DOI: 10.1016/s0021-9258(18)35957-x] [Cited by in Crossref: 26] [Article Influence: 0.9] [Reference Citation Analysis]
21 Quintana A, Raczka E, Piehler L, Lee I, Myc A, Majoros I, Patri AK, Thomas T, Mulé J, Baker JR Jr. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res 2002;19:1310-6. [PMID: 12403067 DOI: 10.1023/a:1020398624602] [Cited by in Crossref: 481] [Cited by in F6Publishing: 87] [Article Influence: 25.3] [Reference Citation Analysis]
22 Wakasugi A, Asakawa M, Kogiso M, Shimizu T, Sato M, Maitani Y. Organic nanotubes for drug loading and cellular delivery. International Journal of Pharmaceutics 2011;413:271-8. [DOI: 10.1016/j.ijpharm.2011.04.038] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
23 Ashokkumar B, Mohammed ZM, Vaziri ND, Said HM. Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells. Am J Clin Nutr 2007;86:159-66. [PMID: 17616776 DOI: 10.1093/ajcn/86.1.159] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 5.1] [Reference Citation Analysis]
24 Hu Y, Liu W, Wu F. Novel multi-responsive polymer magnetic microgels with folate or methyltetrahydrofolate ligand as anticancer drug carriers. RSC Adv 2017;7:10333-44. [DOI: 10.1039/c6ra27114f] [Cited by in Crossref: 16] [Article Influence: 3.2] [Reference Citation Analysis]
25 Lewis CM, Smith AK, Nguyen C, Kamen BA. PMA alters folate receptor distribution in the plasma membrane and increases the rate of 5-methyltetrahydrofolate delivery in mature MA104 cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1998;1401:157-69. [DOI: 10.1016/s0167-4889(97)00126-2] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
26 Freisheim JH, Price EM, Ratnam M. Folate coenzyme and antifolate transport proteins in normal and neoplastic cells. Advances in Enzyme Regulation 1989;29:13-26. [DOI: 10.1016/0065-2571(89)90091-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.5] [Reference Citation Analysis]
27 Abdelmawla S, Guo S, Zhang L, Pulukuri SM, Patankar P, Conley P, Trebley J, Guo P, Li QX. Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery. Mol Ther 2011;19:1312-22. [PMID: 21468004 DOI: 10.1038/mt.2011.35] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 7.2] [Reference Citation Analysis]
28 Saltan N, Kutlu HM, Hür D, Işcan A, Say R. Interaction of cancer cells with magnetic nanoparticles modified by methacrylamido-folic acid. Int J Nanomedicine 2011;6:477-84. [PMID: 21468352 DOI: 10.2147/IJN.S16803] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.2] [Reference Citation Analysis]
29 Oyewumi MO, Mumper RJ. Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles. International Journal of Pharmaceutics 2003;251:85-97. [DOI: 10.1016/s0378-5173(02)00587-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
30 Zhang LK, Hou SX, Zhang JQ, Hu WJ, Wang CY. Preparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticles. Arch Pharm Res 2010;33:1193-8. [PMID: 20803122 DOI: 10.1007/s12272-010-0809-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
31 Sagir T, Huysal M, Senel M, Isık S, Burgucu N, Tabakoglu O, Zaim M. Folic acid conjugated PAMAM-modified mesoporous silica-coated superparamagnetic iron oxide nanoparticles for potential cancer therapy. J Colloid Interface Sci 2022;625:711-21. [PMID: 35772201 DOI: 10.1016/j.jcis.2022.06.069] [Reference Citation Analysis]
32 Bhandari SD, Joshi SK, Mcmartin KE. Folate binding and transport by rat kidney brush-border membrane vesicles. Biochimica et Biophysica Acta (BBA) - Biomembranes 1988;937:211-8. [DOI: 10.1016/0005-2736(88)90243-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
33 Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Advanced Drug Delivery Reviews 2002;54:675-93. [DOI: 10.1016/s0169-409x(02)00042-x] [Cited by in Crossref: 596] [Cited by in F6Publishing: 163] [Article Influence: 29.8] [Reference Citation Analysis]
34 Wollack JB, Makori B, Ahlawat S, Koneru R, Picinich SC, Smith A, Goldman ID, Qiu A, Cole PD, Glod J, Kamen B. Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture model. J Neurochem 2008;104:1494-503. [PMID: 18086128 DOI: 10.1111/j.1471-4159.2007.05095.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 3.7] [Reference Citation Analysis]
35 Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Advanced Drug Delivery Reviews 2012;64:342-52. [DOI: 10.1016/j.addr.2012.09.020] [Cited by in Crossref: 215] [Cited by in F6Publishing: 153] [Article Influence: 21.5] [Reference Citation Analysis]
36 Villanueva J, Ling EH, Chandler CJ, Halsted CH. Membrane and tissue distribution of folate binding protein in pig. Am J Physiol 1998;275:R1503-10. [PMID: 9791067 DOI: 10.1152/ajpregu.1998.275.5.R1503] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
37 Sierra EE, Brigle KE, Spinella MJ, Goldman ID. Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells. Biochem Pharmacol 1995;50:1287-94. [PMID: 7488246 DOI: 10.1016/0006-2952(95)94097-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
38 Graham ML, Shuster JJ, Kamen BA, Cheo DL, Harrison MP, Leventhal BG, Pullen DJ, Whitehead VM. Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: a Pediatric Oncology Group pilot study. Cancer Chemother Pharmacol 1992;31:217-22. [PMID: 1464159 DOI: 10.1007/BF00685551] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
39 Quinlivan EP, Hanson AD, Gregory JF. The analysis of folate and its metabolic precursors in biological samples. Anal Biochem 2006;348:163-84. [PMID: 16266679 DOI: 10.1016/j.ab.2005.09.017] [Cited by in Crossref: 93] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
40 Turk MJ, Waters DJ, Low PS. Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. Cancer Letters 2004;213:165-72. [DOI: 10.1016/j.canlet.2003.12.028] [Cited by in Crossref: 135] [Cited by in F6Publishing: 135] [Article Influence: 7.5] [Reference Citation Analysis]
41 Weitman SD, Frazier KM, Kamen BA. The folate receptor in central nervous system malignancies of childhood. J Neuro-Oncol 1994;21:107-12. [DOI: 10.1007/bf01052894] [Cited by in Crossref: 79] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
42 Kumar P, Huo P, Liu B. Formulation Strategies for Folate-Targeted Liposomes and Their Biomedical Applications. Pharmaceutics 2019;11:E381. [PMID: 31382369 DOI: 10.3390/pharmaceutics11080381] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 8.3] [Reference Citation Analysis]
43 Mumper RJ, Cui Z, Oyewumi MO. Nanotemplate Engineering of Cell Specific Nanoparticles. Journal of Dispersion Science and Technology 2007;24:569-88. [DOI: 10.1081/dis-120021814] [Cited by in Crossref: 28] [Article Influence: 1.9] [Reference Citation Analysis]